126 related articles for article (PubMed ID: 3969535)
1. Binding of human IgA fragments to protein A-Sepharose studied with an ELISA method.
Bruin G; Faber A; Biewenga J
Scand J Immunol; 1985 Jan; 21(1):49-54. PubMed ID: 3969535
[TBL] [Abstract][Full Text] [Related]
2. Comparison of mechanisms of interaction between protein A from Staphylococcus aureus and human monoclonal IgG, IgA and IgM in relation to the classical FC gamma and the alternative F(ab')2 epsilon protein A interactions.
Inganäs M
Scand J Immunol; 1981; 13(4):343-52. PubMed ID: 7302528
[TBL] [Abstract][Full Text] [Related]
3. Activation of complement by human serum IgA, secretory IgA and IgA1 fragments.
Hiemstra PS; Biewenga J; Gorter A; Stuurman ME; Faber A; van Es LA; Daha MR
Mol Immunol; 1988 Jun; 25(6):527-33. PubMed ID: 3173354
[TBL] [Abstract][Full Text] [Related]
4. Cleavage of protein A-binding IgA1 with IgA1 protease from Streptococcus sanguis.
Biewenga J; Daus F
Immunol Commun; 1983 Oct; 12(5):491-500. PubMed ID: 6358000
[TBL] [Abstract][Full Text] [Related]
5. Binding of human IgA myeloma proteins to protein A. Evidence for different binding mechanisms.
Biewenga J; Daus F; Modderman ML; Bruin GM
Immunol Commun; 1982; 11(3):189-200. PubMed ID: 7141462
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of binding of human IgA subclasses to protein A.
Brunda MJ; Minden P; Grey HM
J Immunol; 1979 Oct; 123(4):1457-61. PubMed ID: 113457
[TBL] [Abstract][Full Text] [Related]
7. Human IgA and IgG F(ab')2 that bind to staphylococcal protein A belong to the VHIII subgroup.
Sasso EH; Silverman GJ; Mannik M
J Immunol; 1991 Sep; 147(6):1877-83. PubMed ID: 1909733
[TBL] [Abstract][Full Text] [Related]
8. Further characterization of the alternative protein-A interaction of immunoglobulins: demonstration of an Fc-binding fragment of protein A expressing the alternative reactivity.
Inganäs M; Johansson SG; Sjöquist J
Scand J Immunol; 1981 Oct; 14(4):379-88. PubMed ID: 7038851
[TBL] [Abstract][Full Text] [Related]
9. Normal human sera contain antibodies directed at Fab of IgA.
Jackson S; Montgomery RI; Mestecky J; Czerkinsky C
J Immunol; 1987 Apr; 138(7):2244-8. PubMed ID: 3494062
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory activity of human IgA antibodies and their Fab alpha fragments: inhibition of IgG-mediated complement activation.
Russell MW; Reinholdt J; Kilian M
Eur J Immunol; 1989 Dec; 19(12):2243-9. PubMed ID: 2606139
[TBL] [Abstract][Full Text] [Related]
11. The interaction between different domains of staphylococcal protein A and human polyclonal IgG, IgA, IgM and F(ab')2: separation of affinity from specificity.
Ljungberg UK; Jansson B; Niss U; Nilsson R; Sandberg BE; Nilsson B
Mol Immunol; 1993 Oct; 30(14):1279-85. PubMed ID: 8413328
[TBL] [Abstract][Full Text] [Related]
12. Distribution of antigenic determinants on human IgA1.
Biewenga J; Oliemans J; Daus F; de Lange G; van Eede P; van Leeuwen F; van Loghem E
Vox Sang; 1983; 45(6):426-31. PubMed ID: 6197812
[TBL] [Abstract][Full Text] [Related]
13. [Suppression on normal human lymphocyte proliferation induced by Sepharose 4B binding staphylococcal protein A through addition of human IgG, heat-aggregated IgG, F(ab')2 gamma, Fab gamma and aggregated Fc gamma].
Ohno I; Kobayashi K; Tabata M; Sato H; Sekine F; Negishi M; Ide H; Takahashi T
Arerugi; 1984 Jul; 33(7):411-7. PubMed ID: 6333861
[No Abstract] [Full Text] [Related]
14. The group A streptococcal receptor for human IgA binds IgA via the Fc-fragment.
Schalén C
Acta Pathol Microbiol Scand C; 1980 Oct; 88(5):271-4. PubMed ID: 7008500
[TBL] [Abstract][Full Text] [Related]
15. Production and characterization of pepsin fragments of human IgA1 to determine domain-specificity of monoclonal anti-IgA antibodies.
Biewenga J; Faber A; Pronk JC; Haaijman JJ
Immunology; 1986 Sep; 59(1):153-8. PubMed ID: 3093370
[TBL] [Abstract][Full Text] [Related]
16. Use of monoclonal antibodies and F(ab')2 enzyme conjugates in ELISA for IgM, IgA and IgG rheumatoid factors.
Teitsson I; Valdimarsson H
J Immunol Methods; 1984 Jul; 71(2):149-61. PubMed ID: 6376635
[TBL] [Abstract][Full Text] [Related]
17. Comparison by 1H NMR of the hapten environment in the combining site of the dinitrophenyl binding IgA protein 315 and its fragments.
Morris AT; Givol D; Dwek RA
Immunochemistry; 1978 Aug; 15(8):519-22. PubMed ID: 730222
[No Abstract] [Full Text] [Related]
18. Monoclonal antibodies against different domains of human IgA: specificities determined by immunoblotting and haemagglutination-inhibition.
Biewenga J; Faber A; de Lange G; van Leeuwen F; van Eede P; Jefferis R; Haaijman JJ; Vlug A
Mol Immunol; 1986 Jul; 23(7):761-7. PubMed ID: 2432412
[TBL] [Abstract][Full Text] [Related]
19. Increased serum levels of IgA1-IgG immune complexes and anti-F(ab')2 antibodies in patients with primary IgA nephropathy.
Schena FP; Pastore A; Ludovico N; Sinico RA; Benuzzi S; Montinaro V
Clin Exp Immunol; 1989 Jul; 77(1):15-20. PubMed ID: 2788538
[TBL] [Abstract][Full Text] [Related]
20. Human IgA1 blockade of IgG-initiated lysis of Neisseria meningitidis is a function of antigen-binding fragment binding to the polysaccharide capsule.
Jarvis GA; Griffiss JM
J Immunol; 1991 Sep; 147(6):1962-7. PubMed ID: 1909736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
